PlainPharmaWatch

CMS Open Payments · Program Year 2024

BioLineRx USA, Inc.

BioLineRx USA, Inc. reported $3,252,822.72 in payments to 137 physicians and teaching hospitals across 169 transactions.

See the rankings → How this is sourced
$3.3M
Total payments
169
Transactions
137
Recipients
#344
of 1,925 companies

BioLineRx USA, Inc. reported $3,252,822.72 in payments to 137 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #344 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $23.7K per recipient across 5 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

BioLineRx USA, Inc. pairs top-quartile payment volume with a broadly spread payment pattern across many recipients.

#344
of 1,925 companies
0.0%
of all US industry payments
0.2%
paid to its single top recipient
5
payment categories

How BioLineRx USA, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

BioLineRx USA, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$3,252,823 Top 18% higher than 82% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for BioLineRx USA, Inc.

Averaging $19.2K per transaction and $23.7K per recipient, BioLineRx USA, Inc.'s Program Year 2024 total comes to $3,252,822.72 across 169 transactions and 137 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #344 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $61.4K, accounting for 1.9% of the company's reported total and 29 transactions.

General Payment Breakdown by Type

Across 5 types of general payments, BioLineRx USA, Inc.'s largest category was "Consulting Fee" at $61.4K - 1.9% of the company's reported total.

How BioLineRx USA, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Consulting Fee$61.4K2. Compensation for Faculty …$20.8K3. Grant$20.5K4. Food and Beverage$6.6K5. Travel and Lodging$3.0K
Payment Type Amount Transactions
Consulting Fee $61.4K 29
Compensation for Faculty or Speaker (Medical Education) $20.8K 8
Grant $20.5K 3
Food and Beverage $6.6K 90
Travel and Lodging $3.0K 7

Recipient Concentration in General Payments

The five largest recipient relationships account for $51,500.47 (45.9%) of $112,250.24 in this company's General Payments records across 88 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for BioLineRx USA, Inc.

The five named recipients with the highest reported General Payments from this company

Henry Fung$19.5KZachary D Crees$9.0KKarmanos Cancer Hospital$8.0KStephan Grupp$7.5KScripps Memorial Hospital-En…$7.5K
  1. 1

    Henry Fung

    $19,479.96 across 10 reported transactions

  2. 2

    Zachary D Crees

    $9,000.00 across 3 reported transactions

  3. 3

    Karmanos Cancer Hospital

    $8,000.00 across 1 reported transactions

  4. 4

    Stephan Grupp

    $7,520.51 across 4 reported transactions

  5. 5

    Scripps Memorial Hospital-Encinitas

    $7,500.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $19.2K. Average per recipient: $23.7K.

Total Amount

$3,252,822.72

Avg per Transaction

$19.2K

Avg per Recipient

$23.7K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

BioLineRx USA, Inc. Share

0.0%

#344 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to BioLineRx USA, Inc.

Chugai Pharmaceutical Co., Ltd.

$3.2M 133 recipients

Endo USA, Inc.

$3.2M 10,750 recipients

BeiGene AUS Pty Ltd

$3.2M 0 recipients

Kowa Holdings America, Inc.

$3.3M 0 recipients

Phasor Health, LLC

$3.2M 0 recipients

Viseon, Inc.

$3.2M 67 recipients

Frequently Asked Questions

How much did BioLineRx USA, Inc. pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from BioLineRx USA, Inc., totaling $3,252,822.72 across 169 transactions to physicians and hospitals.
How many physicians received payments from BioLineRx USA, Inc.? ▾
137 physicians and teaching hospitals received payments from BioLineRx USA, Inc. in 2024, averaging $23.7K per recipient.
What types of payments did BioLineRx USA, Inc. make? ▾
General payments from BioLineRx USA, Inc. span 5 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Consulting Fee" at $61.4K, representing 1.9% of the company's reported total.
How does BioLineRx USA, Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, BioLineRx USA, Inc. ranks #344 by total payment amount.
What is the average payment size from BioLineRx USA, Inc.? ▾
In 2024, BioLineRx USA, Inc. averaged $19.2K per transaction across 169 transactions to 137 recipients.
Where does the payment data for BioLineRx USA, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download BioLineRx USA, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.